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which oxidizes H2S to persulfide. SQRs were 
initially identified in invertebrates, and their 
mammalian counterpart SQRs were later 
discovered (Theissen et al., 2003; Theissen 
and Martin, 2008). In the presence of O2 and 
water, sulfur dioxygenase oxidizes persulfide 
to sulfite, which is combined with another 
persulfide molecule by sulfur transferase 
rhodanese in order to producing thiosulfate 
(Figure 1). Because H2S consumption by a 
dioxygenase is high in the presence of O2 
(Furne et al., 2008), high H2S production is 
offset by rapid H2S clearance under aerobic 
conditions, accounting for very low basal 
levels of H2S. Small deviations in the rates 
of H2S production and clearance may lead 
to rapid and several-fold changes in the H2S 
levels (Vitvitsky et al., 2012).
Storage of H2S aS bound Sulfane 
Sulfur and itS aSSociated releaSe
In addition to enzymatic regulation of 
H2S levels, H2S may be stored in proteins 
as bound sulfane sulfur that is divalent 
sulfur bound mostly to sulfur of cysteine 
residues. (Ishigami et al., 2009) (Figure 1). 
Exogenously applied H2S is absorbed and 
stored as bound sulfane sulfur, and the 
rate of absorption varies according to tis-
sue types. Cells expressing 3MST and CAT 
have higher levels of bound sulfane sulfur 
than control cells (Shibuya et al., 2009a,b). 
In contrast, cells expressing 3MST mutants 
– that lack the ability to produce H2S – 
retain control-like levels of bound sulfane 
sulfur. Therefore, H2S produced by enzymes 
is stored in cells as bound sulfane sulfur. 
Bound sulfane sulfur releases H2S under 
reducing conditions. In the presence of 
major cellular reducing substances, glu-
tathione, cysteine, and dihydrolipoic acid 
(DHLA) at their physiologic concentra-
tions, H2S is released from lysates of cul-
tured neurons and astrocytes at pH 8.0–8.4 
(Ishigami et al., 2009; Mikami et al., 2011a). 
When neurons are excited, sodium ions 
enter and potassium ions exit from cells, 
resulting in high potassium concentrations 
in the extracellular environment, which 
these methods give concentration estimates 
of 20 nM to a few micromolar in tissue and 
blood samples (Furne et al., 2008; Ishigami 
et al., 2009; Wintner et al., 2010).
 It is necessary to determine the active 
state concentrations of H2S. At least three 
factors influence H2S concentration: (1) rate 
of H2S production, (2) rate of H2S metabo-
lism, and (3) storage of H2S as bound sul-
fane sulfur and its associated release.
rate of H2S production
H2S production by three enzymes has been 
studied extensively; these enzymes are cys-
tathionine β-synthase (CBS), cystathionine 
γ-lyase (CSE), and 3-mercaptopyruvate sul-
furtransferase (3MST; Stipanuk and Beck, 
1982; Chiku et al., 2009; Shibuya et al., 
2009a,b; Singh et al., 2009) (Figure 1). 
CBS and CSE metabolize cysteine and/
or homocysteine to release H2S, whereas 
3MST produces H2S from 3-mercapto-
pyruvate (3MP), which is produced by the 
action of cysteine aminotransferase (CAT) 
on cysteine and α-ketoglutarate (Cooper, 
1983; Shibuya et al., 2009a,b). 3MST 
requires cofactors to reduce a persulfide 
intermediate generated between a cysteine 
residue of 3MST and a sulfide provided by 
3MP. We recently found that thioredoxin 
and dihydrolipoic acid (DHLA) are endog-
enous reducing cofactors that facilitate H2S 
release from 3MST (Mikami et al., 2011a). 
We also found that the 3MST/CAT pathway 
is regulated by Ca2+ (Mikami et al., 2011b; 
Mikami and Kimura, 2012) and that the 
activity of CBS is enhanced by S-adenosyl 
methionine (SAM; Abe and Kimura, 1996). 
Thus, the physiological stimuli that alter the 
intracellular levels of Ca2+ and SAM should 
be investigated in order to clarify the regula-
tion of H2S production.
rate of H2S metaboliSm
H2S is metabolized in the mitochon-
dria, via the sulfide oxidation pathway 
(Hildebrandt and Grieshaber, 2008). The 
first step is catalyzed by a membrane-bound 
sulfide:quinone oxidoreductase (SQR), 
More than 15 years have passed since 
  hydrogen sulfide (H2S) emerged as a bio-
logical signaling molecule – initially, in 
the nervous and vascular systems through 
the modulation of N-methyl d-aspartate 
(NMDA) receptors and the activation of 
transmembrane receptor potential (TRP)- 
and ATP-dependent K+ (KATP)-channels 
(Abe and Kimura, 1996; Hosoki et al., 1997; 
Dello Russo et al., 2000; Zhao et al., 2001; 
Teague et al., 2002; Nagai et al., 2004; Streng 
et al., 2008), and later, in nearly every organ 
system (Predmore and Lefer, 2010). H2S was 
found to play a role as a cytoprotectant in 
the nervous system (Kimura and Kimura, 
2004; Whiteman et al., 2004); this finding 
led to the discovery of the cardioprotective 
effect of H2S (Elrod et al., 2007) (Figure 1). 
Previous studies have also described that 
H2S plays several roles: as a regulator of 
insulin release, inflammation, and angio-
genesis, and as an oxygen (O2) sensor (Li 
et al., 2005; Yang et al., 2005; Kaneko et al., 
2006; Olson et al., 2006; Zanardo et al., 
2006; Cai et al., 2007; Papapetropoulos 
et al., 2009).
 Previous studies report measurement 
of endogenous concentrations of sulfide by 
methods involving high concentrations of 
acids; therefore, contamination by free H2S 
released from acid-labile sulfur resulted in 
an overestimate of the free H2S levels (50–
160 μM; Goodwin et al., 1989; Warenycia 
et al., 1989; Savage and Gould, 1990). A 
sulfur/silver electrode has frequently been 
used for the measurement of sulfide con-
centrations in biological samples. The elec-
trode measures the level of S2−, and a pKa 
value of 13.9 results in the replacement of 
cysteine sulfide groups in proteins with 
hydroxyl groups, thereby releasing H2S 
from proteins. Because tissue and blood 
samples contain abundant proteins, this 
method estimates erroneously high con-
centrations of sulfide (Whitfield et al., 
2008). Recently, the basal or steady state 
endogenous concentrations of H2S have 
been re-evaluated using methods that avoid 
release of contaminant H2S from proteins; 
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trations and the effective-concentrations 
of exogenously applied H2S has been dis-
cussed frequently. Some effects of H2S may 
be elicited by its entry into cells through 
the plasma membrane. However, the rate of 
permeation and how freely and rapidly H2S 
diffuses within the cytosol have not been 
determined. We also need to clarify the 
H2S concentrations reached when cells are 
stimulated and the associated mechanism.
In conclusion, the basal or steady state 
levels of H2S have been re-evaluated and 
found to be much lower than those previ-
ously reported. There is a difference between 
the steady state- and the effective-concen-
trations of H2S. Therefore, it is urgent to 
determine the local concentrations of H2S 
achieved when cells are stimulated.
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